FDA chief: Personalized medicine will spur industry collaborations

11/11/2008 | Philadelphia Inquirer, The

Major medical advances and scientific discoveries will bring together drugmakers, small biotech firms and medical-device manufacturers to develop more personalized treatments for patients with cancer and other life-threatening diseases, according to FDA chief Dr. Andrew von Eschenbach. These developments also could change the way companies test treatments and force the FDA to overhaul its drug-review process, von Eschenbach said.

View Full Article in:

Philadelphia Inquirer, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
PacificSource
Boise, ID